all glp-1 drugs medications get at the heart of addiction: study – WashU Medicine Patient education tips for GLP-1,
Description
The FDA has approved glucagon-like peptide-1 (GLP-1) receptor agonists such as Liraglutide, Semaglutide, and the GLP-1/gastric inhibitory polypeptide (GIP) dual agonist Tirzepatide for the treatment of obesity

No side effects like the nausea or headache

Noticing hair thinning during GLP-1 weight loss

The findings revealed a crucial insight, for some GLP-1 s like Saxenda and Wegovy, the high cost of ongoing use surpasses the cost of RYGB in less than a year and sleeve gastrectomy within nine months

Recent evidence suggests these drugs also benefit heart, kidney, liver, and even brain health

Benefits, risks, and doctor-guided strategies explained.
